Eisai
(OTC) ESALY
Eisai Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$737.10B
Net Income (TTM)
$27.05B
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ESALY News
5 Freakishly Expensive Cancer Drugs
ESALY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eisai
Industry
Pharmaceuticals
Sector
Health CareEmployees
11,067
CEO
Haruo Naito
Website
www.eisai.co.jpHeadquarters
Tokyo, 112-8088, JP
ESALY Financials
Key Financial Metrics (TTM)
Gross Margin
78%
Operating Margin
6%
Net Income Margin
5%
Return on Equity
5%
Return on Capital
4%
Return on Assets
3%
Earnings Yield
N/A
Dividend Yield
3.31%
Payout Ratio
1.06%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$581.39B
Operating Income
$58.39B
EBITDA
$94.55B
Operating Cash Flow
$117.59B
Capital Expenditure
$40.47B
Free Cash Flow
$77.12B
Cash & ST Invst.
$310.06B
Total Debt
$94.89B
Eisai Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$187.57B
-7.6%
Gross Profit
$140.84B
-11.3%
Gross Margin
75.08%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
11,092
N/A
Net Income
$9.12B
-30.1%
EBITDA
$20.23B
-16.4%
Quarterly Fundamentals
Net Cash
$118.86B
-29.8%
Accounts Receivable
$0.00
N/A
Inventory
$120.86B
+30.6%
Long Term Debt
$84.92B
+70.1%
Short Term Debt
$65.20B
+63.0%
Return on Assets
2.88%
N/A
Return on Invested Capital
4.10%
N/A
Free Cash Flow
$14.06B
-141.4%
Operating Cash Flow
$6.92B
-245.2%